Tumor infiltrating lymphocytes: The regulator of melanoma evolution

• Published in: Oncology letters Vol. 17; no. 5; pp. 4155 - 4161
• Main Authors: Antohe, Mihaela, Nedelcu, Roxana Ioana, Nichita, Luciana, Popp, Cristiana Gabriela, Cioplea, Mirela, Brinzea, Alice, Hodorogea, Anastasia, Calinescu, Andreea, Balaban, Mihaela, Ion, Daniela Adriana, Diaconu, Carmen, Bleotu, Coralia, Pirici, Daniel, Zurac, Sabina Andrada, Turcu, Gabriela
• Format: Journal Article
• Language: English
• Published: Greece Spandidos Publications 01.05.2019; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Analysis; Antibodies; Antigens; B cells; Biological markers; Cancer; Cell death; Dendritic cells; Diagnosis; Immune response; Immune system; Immunotherapy; Lymphatic system; Lymphocytes; Macrophages; Medical prognosis; Melanoma; Metastasis; Mutation; Oncology; Patients; Prognosis; Review; Skin; Skin cancer; T cells; Tumors; Women; melanoma; dendritic cells; immunogenic tumor; immunoediting
• DOI: 10.3892/ol.2019.9940
• ISSN: 1792-1074

Melanoma is the most severe type of skin cancer and its incidence has increased in the last decades. In the United States, it is the 6th most common cancer in both men and women. Prognosis for patients with melanoma depends on the stage of the disease at the time of diagnosis and it can be influenced by the immunologic response. Melanoma has been historically considered an immunogenic malignancy. It often contains great amount of immune cells (different subsets of T-cells, dendritic cells, macrophages, neutrophils, mast cells, B lymphocytes), which may reflect a continuous intercommunication between host and tumor. It is not established if tumor-infiltrating lymphocytes (TILs) are induced by tumor cells or by other components of the microenvironment or when they are a host direct immunologic reaction. It has been observed that in many cases, the presence of a dense TIL is associated with good prognosis. The pattern and activation state of the cells which constitute TIL is variable and modulates the clinical outcome. An important step in the understanding of tumor immunobiology is the analysis of the populations and subsets of immune cells that form TIL. Besides its prognostic significance, after approval of cytotoxic T lymphocyte antigen 4, programmed cell death-1 and programmed death-1 ligand antibodies for the treatment of melanoma, the assessment of immune infiltrate composition has become even more captivating, as it could provide new target molecules and new biomarkers for predicting the effect of the treatment and disease outcome in patients treated with immunotherapy. In this review we discuss current state of knowledge in the field of immune cells that infiltrate melanoma, resuming the potential of TIL components to become prognostic markers for natural evolution, for response to drugs or valuable targets for new medication.